crohn's disease and glp-1 SAFETY CLINICAL EFFECTIVENESS OF GLP1 AGONISTS IN INFLAMMATORY BOWEL PATIENTS GLP-1 RAs and Crohn's Disease

GLP-1 receptor agonists have been shown to increase dopamine and serotonin release in the brain, which may contribute to their effects on appetite and satiety

Why Microdosing GLP-1 matters for longevity What AgelessRx customers are saying The above testimonials are from real AgelessRx customers sourced from Trustpilot.com

Hormonal factors particularly affect women, as menstrual cycles, birth control, and underlying hormonal conditions can influence treatment response

Neuroinflammation in Alzheimers Disease: Current Evidence and Future Directions

Conclusion This study highlights the wide-ranging impacts of GLP-1 receptor agonists on mental health outcomes